Clinical trial
Effect of Auricular Acupressure Added to Standard Triple Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Multicenter Randomized Double-Blind Sham-Controlled Trial
NCT07760766 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Auricular Acupressure Added to Standard Triple Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Multicenter Randomized Double-Blind Sham-Controlled Trial
- Lead sponsor
- China Medical University, China
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 332 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapy-induced nausea and vomiting